Svexa's CoB Prof Euan Ashley interviewed about his recent genome sequencing results

Our Founder and Chairman of the Board Prof Euan Ashley heads a team at Stanford that is leading the world's innovation in areas of precision medicine and genetics. Recently he spoke with Damian Whitworth of The Times UK about the interesting results of his own genome sequencing.

READ THE ARTILCE NOW (The Times pay wall)

Euan is Associate Dean and Professor of Cardiovascular Medicine and Genetics at Stanford University in California, and co-director of Stanford Medicine Catalyst - a program to support Stanford faculty, staff and students looking to take their scientific and technical discoveries to the next stage of execution. His research focuses on genetic mechanisms of cardiovascular health and disease. In addition to wet bench science, his lab leverages AI and digital health tools, working with biotechnology and technology partners in Silicon Valley.

He recently published the book "The Genome Odyssey: Medical Mysteries and the Incredible Quest to Solve Them", reviewed recently in the Wall Street Journal and Readers' Digest.

Euan has received many awards including recognition from the Obama White House for contributions to personalized medicine and the American Heart Association’s Medal of Honor for precision medicine. The efforts and improvements in clinical precision medicine that his team leads worldwide is a foundational pillar in Svexa's work in precision health and individualized optimization of training and performance.